What is GenoPalate?
GenoPalate is a science-based nutritional genomics company dedicated to pioneering personalized nutrition. Through at-home DNA tests, one-on-one online nutrition programs guided by registered dietitians, and tailored supplements, GenoPalate leverages evidence-based nutrigenomics research. The company empowers individuals to achieve optimal health by providing actionable insights derived from their unique genetic makeup.
How much funding has GenoPalate raised?
GenoPalate has raised a total of $9.8M across 3 funding rounds:
Series A
$4M
Other Financing Round
$5.6M
Private Equity
$250K
Series A (2020): $4M, investors not publicly disclosed
Other Financing Round (2022): $5.6M, investors not publicly disclosed
Private Equity (2026): $250K, investors not publicly disclosed
What's next for GenoPalate?
The substantial enterprise-level backing and recent strategic investment position GenoPalate for accelerated expansion and innovation. This capital infusion is likely to fuel further research and development in nutrigenomics, enhance its digital platform, and broaden its market reach. The company is poised to solidify its leadership in the rapidly growing personalized wellness sector, capitalizing on the increasing consumer demand for data-driven health solutions.
See full GenoPalate company page
